General information about company | ||
| Scrip code* | 543657 | |
| NSE Symbol* | ACI | |
| MSEI Symbol* | NOTLISTED | |
| ISIN* | INE128X01021 | |
| Name of company | Archean Chemical Industries Limited | |
| Type of company | Main Board | |
| Class of security | Equity | |
| Date of start of financial year | 01-04-2025 | |
| Date of end of financial year | 31-03-2026 | |
| Date of board meeting when results were approved | 14-11-2025 | |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 10-11-2025 | |
| Description of presentation currency | INR | |
| Level of rounding | Lakhs | |
| Reporting Type | Quarterly | |
| Reporting Quarter | Second quarter | |
| Nature of report standalone or consolidated | Standalone | |
| Whether results are audited or unaudited for the quarter ended | Unaudited | |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited | |
| Segment Reporting | Single segment | |
| Description of single segment | Marine Chemicals | |
| Start date and time of board meeting | 14-11-2025 16:30 | |
| End date and time of board meeting | 14-11-2025 18:50 | |
| Whether cash flow statement is applicable on company | Yes | |
| Type of cash flow statement | Cash Flow Indirect | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable | |
| Whether the company has any related party? | Yes | |
| Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | Yes | |
| (I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public | NA | |
| (II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. | NA | |
| (III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)? | No | |
| (a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? | ||
| (b) If answer to above question is No, please explain the reason for not complying. | ||
| Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? | Yes | |
| Latest Date on which RPT policy is updated | 07-02-2025 | |
| Indicate Company website link for updated RPT policy of the Company | https://www.archeanchemicals.com/investor-relations/admin/assets/products/Policy%20on%20RPT-07.02.2025.pdf | |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No | |
| No. of times funds raised during the quarter | ||
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No | Not Applicable |
Financial Results – Ind-AS | ||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | ||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | ||
| Whether results are audited or unaudited | Unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | Standalone | ||
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | |||
| 1 | Income | |||
| Revenue from operations | 22076.01 | 49939 | ||
| Other income | 1102.13 | 2384.37 | ||
| Total income | 23178.14 | 52323.37 | ||
| 2 | Expenses | |||
| (a) | Cost of materials consumed | 1037.73 | 2482.26 | |
| (b) | Purchases of stock-in-trade | 0 | 1652.44 | |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | -1936.11 | -3754.13 | |
| (d) | Employee benefit expense | 1442.35 | 3092.59 | |
| (e) | Finance costs | 449.65 | 895.49 | |
| (f) | Depreciation, depletion and amortisation expense | 2039.28 | 4021.7 | |
| (g) | Other Expenses | |||
| 1 | Other Expenses | 15035.12 | 31671.61 | |
| Total other expenses | 15035.12 | 31671.61 | ||
| Total expenses | 18068.02 | 40061.96 | ||
| 3 | Total profit before exceptional items and tax | 5110.12 | 12261.41 | |
| 4 | Exceptional items | 0 | 0 | |
| 5 | Total profit before tax | 5110.12 | 12261.41 | |
| 6 | Tax expense | |||
| 7 | Current tax | 1089.17 | 3021.71 | |
| 8 | Deferred tax | 174.68 | 208.58 | |
| 9 | Total tax expenses | 1263.85 | 3230.29 | |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 | |
| 11 | Net Profit Loss for the period from continuing operations | 3846.27 | 9031.12 | |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 | |
| 13 | Tax expense of discontinued operations | 0 | 0 | |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 | |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 | |
| 16 | Total profit (loss) for period | 3846.27 | 9031.12 | |
| 17 | Other comprehensive income net of taxes | -10.83 | -9.16 | |
| 18 | Total Comprehensive Income for the period | 3835.44 | 9021.96 | |
| 19 | Total profit or loss, attributable to | |||
| Profit or loss, attributable to owners of parent | ||||
| Total profit or loss, attributable to non-controlling interests | ||||
| 20 | Total Comprehensive income for the period attributable to | |||
| Comprehensive income for the period attributable to owners of parent | ||||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | ||||
| 21 | Details of equity share capital | |||
| Paid-up equity share capital | 2468.55 | 2468.55 | ||
| Face value of equity share capital | 2 | 2 | ||
| 22 | Reserves excluding revaluation reserve | |||
| 23 | Earnings per share | |||
| i | Earnings per equity share for continuing operations | |||
| Basic earnings (loss) per share from continuing operations | 3.12 | 7.32 | ||
| Diluted earnings (loss) per share from continuing operations | 3.11 | 7.31 | ||
| ii | Earnings per equity share for discontinued operations | |||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | ||
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | ||
| iii | Earnings per equity share (for continuing and discontinued operations) | |||
| Basic earnings (loss) per share from continuing and discontinued operations | 3.12 | 7.32 | ||
| Diluted earnings (loss) per share from continuing and discontinued operations | 3.11 | 7.31 | ||
| 24 | Debt equity ratio | Textual Information( 1) | ||
| 25 | Debt service coverage ratio | Textual Information( 2) | ||
| 26 | Interest service coverage ratio | Textual Information( 3) | ||
| 27 | Disclosure of notes on financial results | Textual Information(4) | ||
Text Block | |
| Textual Information(4) | Notes to the unaudited standalone financial results: 1.Archean Chemical Industries Limited (ACIL or the Company) was incorporated on July 14, 2009. The Company is into manufacturing Marine Chemicals. The manufacturing location is in Gujarat. 2.The above unaudited standalone financial results have been prepared in accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended and in conformity with Ind AS, as prescribed under Sec 133 of Companies Act, 2013 read with relevant rules issued thereunder and accounting principles generally accepted in India. These unaudited standalone financial results have been reviewed by the Audit Committee, approved by the Board of Directors in the meeting held on November 14, 2025. These unaudited standalone financial results have been subjected to limited review by the statutory auditors of the Company in accordance with Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 ("the Regulations") who have issued an unmodified conclusion on these unaudited standalone financial results. 3. The Company is primarily engaged in the business of manufacture of marine chemicals which is considered as one reportable segment and hence, no additional disclosures with respect to segment information have been made under Ind AS 108 - Operating Segments. The Company entered into Memorandum of Undertaking ( MOU) dated August 10, 20 I0, with Government of Gujarat (GOG) for the Land lease which expired on July 31, 2018 and the Company had made an application for renewal on December 28, 2017. As per the MOU with GOG, the lease term can be further extended for a duration and conditions as mutually agreed at that time. There is also a GOG circular no 1597/1372Rg' dated October 9, 2017 which states that such leases can be extended for a period of thirty years. 4. The Company has also been receiving demand note annually for the revised lease rents as per GoG circular and the company has been making these payments. Management made an assessment of the facts disclosed above and taking into consideration of similar experience during renewal in another group company, is confident of obtaining the renewal of land lease. The Useful life of PPE and ROU assets have been determined by the management considering that the lease would be extended. The entire production facility is located on this leased land. 5. Exceptional item is due to Asna cyclone impact resulting in loss of industrial salt stock of Rs. 4,018.27 lakhs (4.72 Lakhs MT) in Gujarat during August 24 / September 24. The Company has initiated the claim process with the insurance company. 6. ACIL in its Board of Director's Meeting held on 25th October 2024 approved the following investments to be made in one or more tranche in (a) Clas-SiC Wafer Fab Limited, U.K. to the tune of GBP 15 million and additional GBP 2 million as a loan and in (b) Offgrid Energy Labs Inc, Delaware, USA to the tune ofUSD 12 million. a. Clas-SiC Wafer Fab Limited, a UK-based company is specializing in silicon carbide (SiC) MOSFETs/device manufacturing (Semiconductor Indus(ry). ACIL made a strategic investment in Clas-SiC Wafer Fab Limited, a UK-based dedicated Silicon Carbide wafer Foundary with manufacturing capability for SiC Devices. This will be India's first investment in a company with silicon carbide MOSFETS/Devices production capability. This investment aligns with Company's broader semiconductor initiative through SiCSem Private Limited (SiCSem) and secures technology exclusivity in India. ACIL's core competency in specially chemicals, creates natural synergies with its SiC semiconductor business. Accordingly, ACIL subscribed shares in Clas- SiC for GBP 10 Million on October 31,2024 (A-0 Class - 18,51,852, FV GBP 0.01, Acquired price - GBP 5.40 I share); Payment of GBP 2.50 Million was made on November 4, 2024 towards purchase of A-1 Class - 4,62,963 shares for the same price and Share certificates received for the same. During the current period, Balance payment of GBP 2.50 Million was made on May 21, 2025 towards purchase of A-1 Class -4,62,963 shares for the same price and and Share certificates received for the same. b. Offgrid Energy Labs Inc (Offgrid), is an lP-led company specializing in zinc-bromide battery technology. Offgrid has developed a patented battery technology based on Zinc Bromide chemis(ry with significant cost and performance advantages. Offgrid has built a battery technology that is particularly suited to applications requiring daily deep charge and discharge, such as renewable energy storage and low power mobility solutions. The Company has executed the Restated Stockholders Agreement, Stock Subscription Agreement with Offgrid Energy Labs Inc. and its existing stockholders for an investment ofUSD 12 million in a Series A fundraise for securing 21% stake. This investment aligns with the ACIL's broader strategy to enter the energy storage sector, particularly focusing on applications in renewable energy, industrial storage etc. This proposed investment will enable the Company to support Offgrid's requirement of speciality chemicals, manufacturing scale-up, participate in the rapidly growing energy storage market, and create long-term value. ACIL subscribed Al Preferred Stock of 30,669,250 shares with Face value of USD 0.00001 per share, with acquired price of USD 0.32606 per share on May 14,2025 Securing 18.14% stake in Offgiid Energy Labs Inc and the remaining commitment is expected to be made in the subsequent quarters. 7. The Income Tax Department conducted a search and seizure operation from September 4, 2025 to September 9, 2025 at various locations of the Company's and its subsidiary companies' offices, plants, and the residence of directors, senior executives and employees under Section 132 of the Income Tax Act, 1961. The Company, its directors, seinor executives, employees extended full cooperation to the Authorities. Based on preliminary review, the said event does not have any material adverse impact on the financial results of the Company for the quarter and half year ended 30 September 2025. Further, the Company has not received any order/notice/communication on the findings of such investigation by the Income Tax Department as of date. Accordingly, the impact of this matter on the financial results of the Company is presently not ascertainable. 8. SiCSem have received the approval from India Semiconductor Mission (ISM) on August 12, 2025, to setup a Silicon Carbide (SiC) based Compound Semiconductor fab in Info Valley, Bhubaneshwar, Odisha. |
Statement of Asset and Liabilities | |||
| Particulars | Half Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 30-09-2025 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 110735.4 | ||
| Capital work-in-progress | 1118.4 | ||
| Investment property | 0 | ||
| Goodwill | 0 | ||
| Other intangible assets | 4.52 | ||
| Intangible assets under development | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Investments accounted for using equity method | 0 | ||
| Non-current financial assets | |||
| Non-current investments | 26177.49 | ||
| Trade receivables, non-current | 0 | ||
| Loans, non-current | 29312.41 | ||
| Other non-current financial assets | 4223.41 | ||
| Total non-current financial assets | 59713.31 | ||
| Deferred tax assets (net) | 0 | ||
| Other non-current assets | 3074.02 | ||
| Total non-current assets | 174645.65 | ||
| 2 | Current assets | ||
| Inventories | 19598.76 | ||
| Current financial asset | |||
| Current investments | 12593.94 | ||
| Trade receivables, current | 10987.45 | ||
| Cash and cash equivalents | 3773.71 | ||
| Bank balance other than cash and cash equivalents | 1200 | ||
| Loans, current | 30.43 | ||
| Other current financial assets | 1453.26 | ||
| Total current financial assets | 30038.79 | ||
| Current tax assets (net) | 0 | ||
| Other current assets | 6775.51 | ||
| Total current assets | 56413.06 | ||
| 3 | Non-current assets classified as held for sale | 0 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 231058.71 | ||
| Total current assets | 56413.06 | ||
| 3 | Non-current assets classified as held for sale | 0 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 231058.71 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 2468.55 | ||
| Other equity | 190913.56 | ||
| Total equity attributable to owners of parent | 193382.11 | ||
| Non controlling interest | |||
| Total equity | 193382.11 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 4849.44 | ||
| Trade Payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other non-current financial liabilities | 5001.22 | ||
| Total non-current financial liabilities | 9850.66 | ||
| Provisions, non-current | 1505.72 | ||
| Deferred tax liabilities (net) | 12531 | ||
| Deferred government grants, Non-current | 0 | ||
| Other non-current liabilities | 0 | ||
| Total non-current liabilities | 23887.38 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 1286.75 | ||
| Trade Payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 521.43 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 8377.9 | ||
| Total Trade payable | 8899.33 | ||
| Other current financial liabilities | 2214.63 | ||
| Total current financial liabilities | 12400.71 | ||
| Other current liabilities | 255.58 | ||
| Provisions, current | 63.83 | ||
| Current tax liabilities (Net) | 1069.1 | ||
| Deferred government grants, Current | 0 | ||
| Total current liabilities | 13789.22 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | |
| Total liabilities | 37676.6 | ||
| Total equity and liabilities | 231058.71 | ||
| Disclosure of notes on assets and liabilities | Textual Information(1) | ||
Other Comprehensive Income | |||
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of defined benefit obligations | -14.47 | -12.24 |
| Total Amount of items that will not be reclassified to profit and loss | -14.47 | -12.24 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -3.64 | -3.08 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | ||
| 5 | Total Other comprehensive income | -10.83 | -9.16 |
Cash flow statement, indirect | ||||||
| Particulars | Half Year ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | |||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| 1 | Statement of cash flows | |||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 12261.41 | |||||
| 2 | Adjustments for reconcile profit (loss) | |||||
| Adjustments for finance costs | 727.68 | |||||
| Adjustments for decrease (increase) in inventories | -4205.98 | |||||
| Adjustments for decrease (increase) in trade receivables, current | 6148.49 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
| Adjustments for decrease (increase) in other current assets | -576 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0 | |||||
| Adjustments for other financial assets, non-current | 0 | |||||
| Adjustments for other financial assets, current | 0 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | -1900.59 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | -160.37 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | 4021.7 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | -10.75 | |||||
| Adjustments for provisions, non-current | 0 | |||||
| Adjustments for other financial liabilities, current | 0 | |||||
| Adjustments for other financial liabilities, non-current | 0 | |||||
| Adjustments for unrealised foreign exchange losses gains | -2.56 | |||||
| Adjustments for dividend income | 0 | |||||
| Adjustments for interest income | 1172.42 | |||||
| Adjustments for share-based payments | 48.78 | |||||
| Adjustments for fair value losses (gains) | 0 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | -449.47 | |||||
| Other adjustments to reconcile profit (loss) | 0 | |||||
| Other adjustments for non-cash items | 314.06 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | 2782.57 | |||||
| Net cash flows from (used in) operations | 15043.98 | |||||
| Dividends received | 0 | |||||
| Interest paid | 0 | |||||
| Interest received | 0 | |||||
| Income taxes paid (refund) | 2358.03 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | 12685.95 | |||||
| 3 | Cash flows from used in investing activities | |||||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 13.36 | |||||
| Purchase of property, plant and equipment | 777.82 | |||||
| Proceeds from sales of investment property | 0 | |||||
| Purchase of investment property | 0 | |||||
| Proceeds from sales of intangible assets | 0 | |||||
| Purchase of intangible assets | 0 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 0 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | 0 | |||||
| Interest received | 100.74 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | -7074.95 | |||||
| Net cash flows from (used in) investing activities | -7738.67 | |||||
| 4 | Cash flows from used in financing activities | |||||
| Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 0 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | 1267 | |||||
| Repayments of borrowings | 431.76 | |||||
| Payments of lease liabilities | 1611.87 | |||||
| Dividends paid | 3702.83 | |||||
| Interest paid | 286.76 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) financing activities | -4766.22 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 181.06 | |||||
| 5 | Effect of exchange rate changes on cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | 0 | |||||
| Net increase (decrease) in cash and cash equivalents | 181.06 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 3592.65 | |||||
| Cash and cash equivalents cash flow statement at end of period | 3773.71 | |||||
Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter) | ||||||||||||||||||||||||
| Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. | ||||||||||||||||||||||||
| Sr. No. | Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of the related party transaction ratified by the audit committee | Date of Audit Committee Meeting where the ratification was approved | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | ||||||||||||
| Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) | Notes | ||||||||
| 1 | Archean Chemical Industries Limited | AAHCA8471D | P. Ranjit | ADKPR1327C | Key Management Personnel & Other Directors | Any other transaction | Office Rent | 55 | Approved | 24.92 | -4.38 | -4.56 | ||||||||||||
| 2 | Archean Chemical Industries Limited | AAHCA8471D | P. Ranjit | ADKPR1327C | Key Management Personnel & Other Directors | Any other transaction | Remuneration & Commission | Approved | 400.61 | -283.04 | 0 | |||||||||||||
| 3 | Archean Chemical Industries Limited | AAHCA8471D | Acume Chemicals Private Limited | AAWCA1349R | Subsidiary Company | Sale of goods or services | 18000 | Approved | 1704.43 | 0 | 2583.94 | |||||||||||||
| 4 | Archean Chemical Industries Limited | AAHCA8471D | Jakhau Salt Company Private Limited | AAACW0867G | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Reimbursement of Jetty Expenses | 600 | Approved | 79.19 | 0 | 0 | ||||||||||||
| 5 | Archean Chemical Industries Limited | AAHCA8471D | Jakhau Salt Company Private Limited | AAACW0867G | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Reimbursement of Expenses | 50 | Approved | 0 | -101.91 | 0 | ||||||||||||
| 6 | Archean Chemical Industries Limited | AAHCA8471D | Jakhau Salt Company Private Limited | AAACW0867G | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Sale of goods or services | 0 | Approved | 0 | 0 | 0 | |||||||||||||
| 7 | Archean Chemical Industries Limited | AAHCA8471D | Jakhau Salt Company Private Limited | AAACW0867G | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Purchase of goods or services | 2700 | Approved | 1652.44 | 0 | 0 | |||||||||||||
| 8 | Archean Chemical Industries Limited | AAHCA8471D | Goodearth Maritime Private Limited | AABCG3285D | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Sale of goods or services | 50 | Approved | 0 | 50 | 50 | |||||||||||||
| 9 | Archean Chemical Industries Limited | AAHCA8471D | Goodearth Maritime Private Limited | AABCG3285D | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Expenses Towards Jetty Services | 3200 | Approved | 400.49 | 0 | 0 | ||||||||||||
| 10 | Archean Chemical Industries Limited | AAHCA8471D | Goodearth Maritime Private Limited | AABCG3285D | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Shipment Management Fee Expenses | 850 | Approved | 383.43 | 0 | 0 | ||||||||||||
| 11 | Archean Chemical Industries Limited | AAHCA8471D | Goodearth Maritime Private Limited | AABCG3285D | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Reimbursement of Expenses | 900 | Approved | 409.53 | 0 | 0 | ||||||||||||
| 12 | Archean Chemical Industries Limited | AAHCA8471D | Goodearth Maritime Private Limited | AABCG3285D | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Expenses Towards Barge Loading & Transport | 1500 | Approved | 137.16 | 1296.24 | 1253.72 | The opening and closing balance in this line item represents the put together transactions of Goodearth Maritime Private Limited. | |||||||||||
| 13 | Archean Chemical Industries Limited | AAHCA8471D | Sea Salt Holdings Pte Ltd | ZZZZZ9999Z | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Demurrage Expense | 400 | Approved | 30.63 | 0 | 0 | ||||||||||||
| 14 | Archean Chemical Industries Limited | AAHCA8471D | Sea Salt Holdings Pte Ltd | ZZZZZ9999Z | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Sale of goods or services | 9600 | Approved | 2703.99 | 0 | 918.45 | |||||||||||||
| 15 | Archean Chemical Industries Limited | AAHCA8471D | Archean Industries Private Limited | AAACA7344J | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Reimbursement of Expenses | 10 | Approved | 0 | 12.15 | 0 | ||||||||||||
| 16 | Archean Chemical Industries Limited | AAHCA8471D | KGF Granites Private Limited | AAFCK1332H | Enterprise Over Which Key Management Personnel Exercise Significant Influence | Any other transaction | Reimbursement of Expenses | 10 | Approved | 0 | 1.2 | 0 | ||||||||||||
| 17 | Archean Chemical Industries Limited | AAHCA8471D | Chemikas Speciality LLP | AASFG6012G | Entities & Persons Having Significant Influence | Any other transaction | Payment of Rent | 150 | Approved | 66 | 0 | 30.45 | ||||||||||||
| 18 | Archean Chemical Industries Limited | AAHCA8471D | Acume Chemicals Private Limited | AAWCA1349R | Subsidiary Company | Loan | 6000 | Approved | 250 | 9616.71 | 9866.71 | Loan | 7.50% | 112 Months | Unsecured | Business Purpose | ||||||||
| 19 | Archean Chemical Industries Limited | AAHCA8471D | Acume Chemicals Private Limited | AAWCA1349R | Subsidiary Company | Any other transaction | Deposit Placed With Bank To Avail Banking Facilities | 1200 | Approved | 0 | 1200 | 0 | ||||||||||||
| 20 | Archean Chemical Industries Limited | AAHCA8471D | Acume Chemicals Private Limited | AAWCA1349R | Subsidiary Company | Interest received | Approved | 366.7 | 853.76 | -1183.79 | As per loan agreement | |||||||||||||
| 21 | Archean Chemical Industries Limited | AAHCA8471D | Acume Chemicals Private Limited | AAWCA1349R | Subsidiary Company | Any other transaction | Rental Income | Approved | 0.2 | 0 | -0.08 | As per rental agreement | ||||||||||||
| 22 | Archean Chemical Industries Limited | AAHCA8471D | Acume Chemicals Private Limited | AAWCA1349R | Subsidiary Company | Any other transaction | Corporate Gurantee | 5000 | Approved | 0 | 16700 | 16700 | ||||||||||||
| 23 | Archean Chemical Industries Limited | AAHCA8471D | Neun Infra Private Limited | AAJCN1585D | Subsidiary Company | Loan | 25000 | Approved | 2600 | 4710.5 | 7310.5 | Loan | 7.50% | 113 Months | Unsecured | Business Purpose | ||||||||
| 24 | Archean Chemical Industries Limited | AAHCA8471D | Neun Infra Private Limited | AAJCN1585D | Subsidiary Company | Interest received | Approved | 257.72 | 853.76 | -278.08 | As per loan agreement | |||||||||||||
| 25 | Archean Chemical Industries Limited | AAHCA8471D | Neun Infra Private Limited | AAJCN1585D | Subsidiary Company | Any other transaction | Rental Income | Approved | 0.1 | 0 | 0 | As per rental agreement | ||||||||||||
| 26 | Archean Chemical Industries Limited | AAHCA8471D | Idealis Chemicals Private Limited | AAHCI3363E | Subsidiary Company | Loan | 15000 | Approved | 95.68 | 8374.99 | 8470.66 | Loan | 7.50% | 126 Months | Unsecured | Business Purpose | ||||||||
| 27 | Archean Chemical Industries Limited | AAHCA8471D | Idealis Chemicals Private Limited | AAHCI3363E | Subsidiary Company | Interest received | Approved | 317.32 | 627.63 | -913.21 | ||||||||||||||
| 28 | Archean Chemical Industries Limited | AAHCA8471D | Idealis Chemicals Private Limited | AAHCI3363E | Subsidiary Company | Any other transaction | Rental Income | Approved | 0.2 | 0 | -0.04 | |||||||||||||
| 29 | Archean Chemical Industries Limited | AAHCA8471D | Idealis Mudchemie Private Limited | AAACO3649L | Step Down Subsidiary | Loan | 2000 | Approved | 775.24 | 361.43 | 1136.67 | Loan | 7.50% | 112 Months | Unsecured | Business Purpose | ||||||||
| 30 | Archean Chemical Industries Limited | AAHCA8471D | Idealis Mudchemie Private Limited | AAACO3649L | Step Down Subsidiary | Interest received | Approved | 29.42 | 3.65 | -30.12 | As per loan agreement | |||||||||||||
| 31 | Archean Chemical Industries Limited | AAHCA8471D | Idealis Mudchemie Private Limited | AAACO3649L | Step Down Subsidiary | Any other transaction | Rental Income | Approved | 0.2 | 0 | 0 | As per rental agreement | ||||||||||||
| 32 | Archean Chemical Industries Limited | AAHCA8471D | Ravi Pendurthi | AEHPR7148M | Key Management Personnel & Other Directors | Remuneration | Approved | 2.5 | 0 | 0 | ||||||||||||||
| Total value of transaction during the reporting period | 12688.1 | |||||||||||||||||||||||